OVERVIEW

CME: Reducing vascular events and disease progression in type 2 diabetes (T2DM) and optimizing delivery of care is organized by ScientiaCME.

Release Date: December 16, 2021
Expiration Date: December 16, 2023

Activity Description / Statement of Need:
Cardiovascular (CV) disease (CVD) is the leading cause of mortality and morbidity in adults worldwide, accounting for around one-third of mortality in the United States. High blood pressure, diabetes, and obesity are health conditions that can increase the risk of heart disease, and over half of American adults have at least one major risk factor for adverse cardiovascular events. In particular, T2DM is a risk factor, with CV events implicated in the mortality of two-thirds of patients with T2DM. About one and a half million new cases of diabetes mellitus are diagnosed in in the United States each year, and the incidence of T2DM is increasing owing in part to Western-style diets, sedentary lifestyle, and changing demographics, and the disease is the largest contributor to a number of vascular outcomes, including end-stage chronic kidney disease (CKD) and blindness in individuals under age 75. CKD is itself a major CVD risk factor and affects millions, yet the literature shows that patients with CKD are underserved with respect to CV risk reduction efforts.

This activity has been proposed to enhance the knowledge, competence, and performance of several members of HCPs in mitigating heart and kidney disease risk in patients with T2DM while addressing barriers to optimal care.

Learning Objectives:
By the end of the session the participant will be able to:
• Recall the interrelationship between T2DM and: vascular risk factors; major adverse cardiovascular events; and kidney disease.
• List safe, effective, and emerging pharmacotherapeutic risk mitigation strategies for heart and kidney diseases in patients with T2DM and formulate a care plan based on those strategies.
• Summarize scientific evidence and professional guidelines aimed at effective management of cardiovascular and renal risk in patients with T2DM.
• Recognize the benefits of comprehensive management of diabetes, cardiovascular risk, and kidney disease by members of a multidisciplinary healthcare team.
• Describe the following changes strategies to reducing vascular and kidney disease risk in patients with T2DM: Adherence and the role socioeconomic, race, ethnic, and sex play in healthcare disparities.

Additional details will be posted as soon as information is available.

Credits

Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physicians: For maintenance of certification (MOC) credit, you must enter your board certification ID # and birth date correctly. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive MOC credit for this activity. Please note: Not all activities on this site provide MOC credit. If this activity does not specify that it provides MOC credit in this section, then it does NOT provide MOC credit.

Pharmacists:
ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-0000-21-039-H01-P. This is an Application (A)-type activity.

Pharmacists: You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner's responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.  ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

  • 1.5 MOC
  • 1.5 Contact Hours
  • 1.5 AMA PRA Category 1 Credits™
  • 0.15 CEUs

    • TARGET AUDIENCE

    PhysicianNursingPharmacistPhysician AssistantEndocrinologistsCardiologistsNephrologistsHealthcare ProfessionalsNursesPrimary Care PhysiciansNurse Practitioners

    SPECIALITIES

    Vascular Disease
    Quick Linksfooter

    Copyrights © 2026 eMedEvents Corporation, All Rights Reserved